Vedolizumab Safe for Inflammatory Bowel DiseaseVedolizumab Safe for Inflammatory Bowel Disease
Vedolizumab safely treats ulcerative colitis and Crohn's disease, researchers report in a study that integrates safety data from six clinical trials. Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news
More News: Clinical Trials | Crohn's Disease | Gastroenterology | Health | Inflammatory Bowel Disease | Study | Ulcerative Colitis